Abstract

Mycoplasma infections, such as walking pneumonia or pelvic inflammatory diseases, are a major threat to public health. Despite their relatively small physical and genomic size, mycoplasmas are known to elicit strong host immune responses, generally inflammatory, while also being able to evade the immune system. The mycoplasma membrane is composed of approximately two-thirds protein and one-third lipid and contains several lipoproteins that are known to regulate host immune responses. Herein, the immunomodulatory effects of mycoplasma lipoproteins are reviewed. A better understanding of the immunomodulatory effects, both activating and evasive, of Mycoplasma surface lipoproteins will contribute to understanding mechanisms potentially relevant to mycoplasma disease vaccine development and treatment.

Highlights

  • Mycoplasmas cause a wide variety of human disease, such as asthma, bronchiectasis, and pelvic inflammatory diseases (Metaxas et al, 2015)

  • Analysis of the mycoplasmal cell membrane demonstrated that several lipoprotein surface antigens elicit strong immune responses (Muhlradt et al, 1997) through a distinct pathway than that seen with lipopolysaccharides (Rawadi and Roman-Roman, 1996)

  • The M. pneumoniae/IL-8/neutrophil axis likely plays a vital role in the pathogenesis of MPP and mycoplasmas directly induce in vitro production of chemotactic cytokines such as IL-8 by bronchial epithelial cells (Chambaud et al, 1999; Peng et al, 2007; Chen et al, 2016)

Read more

Summary

Introduction

Mycoplasmas cause a wide variety of human disease, such as asthma, bronchiectasis, and pelvic inflammatory diseases (Metaxas et al, 2015). Mycoplasmal lipoproteins may have a major role in regulation of the cytokine response in respiratory epithelial cells during M. pneumoniae infection (Eckmann et al, 1995; Yang et al, 2002). The initial release of proinflammatory cytokines and chemokines by epithelial cells infected by Mycoplasmas can induce early recruitment of immune cells such as neutrophils.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.